Business · 01/07/2016
FDA Releases Draft Guidance for Developing Drugs to Treat Vulvovaginal Candidiasis
The US Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop new treatments for uncomplicated vulvovaginal candidiasis (VVC), a common fungal infection affecting women.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →